Skip to content

Reported May 1, 2025 · Before market open

Revenue$28.5MMiss by $7.1M
EPS-$1.07Miss by $0.01
Revenue estimate$35.6M
EPS estimate-$1.06

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$72.7M
EPS estimate-$0.06

Financials

Q1 2025

Income statement

See full
Revenue$28.5M+1,392%
Gross profit$24.8M+1,569%
Operating income-$78.9M-12.7%
Net income-$94.3M-13.8%
EPS (diluted)-$1.31+7.7%

Balance sheet

See full
Cash & equivalents$212.3M-34.1%
Total debt$203.6M+35.7%
Total equity-$338.4M-128%
Total assets$294.2M-17.5%

Cash flow

See full
Operating cash flow-$84.9M-23.1%
CapEx$18.0K-55.0%
Free cash flow-$84.9M-23.0%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$436.62M-28.2%
Enterprise value$427.87M-1.9%
P/S5.3×-229×

Profitability

See full
Gross margin86.2%+9.1pp
Operating margin-349.8%-171pp
Net margin-422.4%-206pp
FCF margin-345.5%-168pp

Returns & leverage

See full
Current ratio3.6×-4.3×

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$28.5M+1,392%

By product

See full
Voquezna Product$28.5M+1,400%

Versus estimates

Ask the moment Phathom Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Phathom Pharmaceuticals, Inc. report Q1 2025 earnings?
Phathom Pharmaceuticals, Inc. (PHAT) reported Q1 2025 earnings on May 1, 2025 before market open.
What were Phathom Pharmaceuticals, Inc.'s Q1 2025 revenue and EPS?
Phathom Pharmaceuticals, Inc. reported revenue of $28.5M and eps of $-1.07 for Q1 2025.
Did Phathom Pharmaceuticals, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $35.6M by $7.1M. EPS missed the consensus estimate of $-1.06 by $0.01.
How did Phathom Pharmaceuticals, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1391.6% from $1.9M a year earlier and eps grew 24.6% from $-1.42.
Where can I find Phathom Pharmaceuticals, Inc.'s Q1 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-061440) directly on SEC EDGAR. The filing index links above go to sec.gov.